Quantcast

Industry news that matters to you.  Learn more

2011 ISB Systems Biology and P4 Medicine Symposium, Day 2

The first Institute for Systems Biology (ISB) symposium was held in 2002. Now in its 10th year, the Systems Biology and P4 Medicine conference provides a setting for some of the world’s most influential researchers who are leading the way in applying systems biology and systems theory to medicine and health care delivery.

2011 ISB Systems Biology and P4 Medicine Symposium, Day 1

The first Institute for Systems Biology (ISB) symposium was held in 2002. Now in its 10th year, the Systems Biology and P4 Medicine conference provides a setting for some of the world’s most influential researchers who are leading the way in applying systems biology and systems theory to medicine and health care delivery.

VeriStrat Test Identifies Lung Cancer Patients Benefiting from Combination Therapy

Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer (NSCLC) were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Center, Amsterdam, The Netherlands. The intention of the biomarker analysis was to evaluate the ability of the blood-based test, VeriStrat, to predict patient outcomes with the erlotinib plus sorafenib combination regimen.